Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct micronenrographic recordings  by Ferguson, David W. et al.
DAVID W. FERGUSON. MD. FACC. WILLIAM J. RERF. >lD. JEFFREY S. SANDERS. MD. 
WITH THE TECHNICAL ASSISTAPJCF OF JOAN S. KEMPF. LPN 
dyns& were obtained in 10 no&mt~su~jec~ (age 25 i 2 
years, mean t SEM) and 29 Qotientswitb enrt failure (age 
49 t 2 years: New York Heart Awxiotion functional class 
II to IV: tell ventrtrutar ejection fraction 21 .? tie; cardiac 
index = 2.16 f 0.13titedmio par m’; pulmonary caQtt,av 
wedge pmsure 23 * 2 nun HSj. SymQ;thetic n&e &Ii& 
was si@dAcnntly hlghrr In the Q&tents with hex, faisilurv 
(54.7 t 4.5 burstslmin) than in normal rubjwts 116.7 + 2.2 
bunb/min, Q < 0.001). 
Multink linear rem’ession analvxs indicated that wn- 
Heart failure is a problem of increasing magnilude. wi,h an 
estimated 2.3 million Americans currently afflicted wr,h this 
disorder and 400,MH) new cases diagnosed in the United 
Stateseach year(l-3). The numberof hospitaldischargesfor 
heart failure has increased almost threefold in the past 20 
years (4). and in 1981 there were >4 million price visits for 
heart failure (5). Despite current management walepies. the 
lr = -0.85, p < 0.0001). There was a Strong positive 
correlalion between symplthrlic nerve ariivi,) and pubno- 
nacy artery diantolic (r = 0.82, Q < O.OWtI and meen ,r = 
0.81. Q .: O.OtW Qrersurer. Similar rcrrelatians were snn 
>rben patients with heart failure were analyzed aparatety. 
There ras M) rignifwant mrrelatian belwen sympstbetir 
nerw activity and mePa 8rleriat Q+fz.wre, ,ef, vennicular 
dwlion franion tbv radiinurlide venticu,oen~W. PJF- 
0.0601) in p&nt_s &t,h bewt &I&. Thus, sympet&c 
nerw arlivity P, rprt prnttels impairmen, of cardbw per- 
lormance in pl,ienlS with heart faiture. 
LI Am Call Cordial 1990:16:1125-34) 
5 year survival rate for patients with established heart faihwe 
avcragcs only 50% (2.6.7). Deaths appear 10 be due in 
approxirnaely equal proportions 10 sudden cardiac death 
and progression to end-stage pump failure 16.8-W. 
In both animals and humans. hean failure is characlerized 
by neurohumoml excitation. wirb increased plasma levels of 
norepinephrine and vanopressin and increased acliviiy of the 
renin-anglotensin-aldosterone system (I 1.14-23). The Qrog- 
nosis of such patient. appears 10 be related to the degree of 
this na&iiamoral ex ?tatian. at least as assessed by levek 
of plasma rain activtty 021 and norepinephrine (23). Al- 
though lhere is no linear correlation between survival and 
absolute level of norepinephrine. plasma levels at rest permit 
diwimination of a patient’s probability of survival (23). 
Un,il recently, it W&F unclear whether the increased 
cirrulatingnorepinephrine levels in heart failure reltecied the 
facditated release of norepinephrinc from peripheral adren- 
ergic nerves. altered synthesis or metabolism of catechal- 
amines. or both, or increased sympathetic neural outflow 
from ,hc ccnrrat iiciroas sys,em. Utilizing analysis of 
plama kinetic\ a~ Indirect citimates of regional sympathetic 
nerwus “activity,” investigators have recently made obrcr- 
v~t~or~s 1211 that indicate that patients with heart failure have 
elevated circulating levels of norepinephrine as a result of 
both increased release and reduced clearance of the cate- 
cholamine. Using direct measurements of sympathetic nerve 
activity. Ihe authors of recent prelimmary studies (24) at the 
University of lowa have documented that a significant 
component of the increased plasma norepinephrine in such 
patients is B result of increased central efferent sympathetic 
neural outflow. 
To further characterize the significance of neural excita- 
tion in hean failure. the oresent nrosllective study was 
performed in an entirely n;w se& of batients with heart 
failure. The purpose of these studies was to critically inves- 
tigate the relation between direct measurements of efferent 
sympathetic nerve activity and commonly utilized clinical 
and hemodynamic descriptors of heart failure in human 
subjects. 
Methods 
Study subjects. Thirty-nine subjects were examined in 
two study groups: I) 29 patients with heart failure, and 2) IO 
normal control subjects. Hcan failure was defined as any 
clinical cardiac disorder in which palients had the following 
inclusion criteria: I l symptoms of dyspnea and exercise 
intolerance consistent with New York Heart Association 
functional class II to IV (25) and 2) presence of reduced 
cardiac systolic functmn defined as a left ventricularcjcction 
fraction ~40% by radionuclide ventriculography. The pa- 
tients had none of the following exclusion criteria: I) mvo- 
cardial infarction within 30 d&s. 2) unstable angina.~ 3) 
significant obstructive valvular or hypertrophic heart dis- 
ease. 4) need for prompt treatment with cardiac medications 
(other than diuretic drugs and nitratco) that could not be 
discontinued for four pharmacologic half-lives before study, 
5) presence of other systemic disorders associated with 
diriurhances in autonomic control of the circulation (for 
example, diabetes, hypertension and idiopathic orthostatic 
hypotension), or61 required continuance ofmedications that 
alter autonomic control mechanisms (for example, antiar- 
rhythmic agents. adrenergic agonists and antawdsts. cal- 
cium channel blockers and psychotropic agents). 
Digitalis glycosidcs were discontinued for a minimum of7 
days before study: this was confirmed by negative findings in 
the d&on serum assay. All oral medications except for 
dturelic drugs were withheld for a minimum of four half- 
lives. and diuretic drugs were withheld for at least I2 h 
before study. Diuretic doses were able in most patients for 
2 to 3 days before studv. Intravenous inotrooic sumxwt that 
WI bei&a.dminiateredto two pat!ents with iean f&e was 
discontinued for a minimum of 6 h before study. All patients 
‘nd a blood count. serum electrolyte levels. renal function 
studies and arterial blood gas dctcrminations performed the 
morning of study. Chest roentgenogram, echocardiogram 
and electrocardiogram (ECG) had been obtained within 2 
days before study and all patients were predominant!y in 
sinus rhythm. 
T/w normnl subjcm were untrained and healthy as as- 
sessed by medical history and physical examination and 
were not receiving any medication. Moreover. these sub- 
jects had normal cardiac functLn at res: 2s assessed by 
echocardiography and right heart catheterization. 
All studies were performed with the subject in the supine 
postabsorptive state. informed written consent was obtained 
from all subjects before study. The protocol was approved 
by the Human Subjects Review Committee of the University 
of Iowa. 
Hemadynamic measuremeilts in patients with heart failure. 
On the morning of study, the patients with heart failure were 
taken to the cardiac catheterization laboratory for complete 
assessment of rest hemodynamics. A 7.SF Row-directed 
oximetry thermodilution Swan-Ganz catheter (American Ed- 
wards Laboratories) was inserted percutaneously under lo- 
cal anesthesia (1% lidocaine. <IO ml) into either the left 
subclavian or right internal jugular vein. A 4F polyethylene 
arterial catheter was placed percutaneously under local 
anesthesia into the right brachial artery. 
Index hemodynamic assessment included systemic afle- 
rial and right heart pressures. Serial right-sided oxygen 
saturation samples excluded an intracardiac lefi to right 
shunt in all patients. Themtodilution cardiac output was 
determined with IO ml iced saline solution injections (five 
measurements) with an SAT-I OximcterKardiac Output 
Computer (American Edwards Laboratories). Simultaneous 
Fick cardiac output was determined by measuring oxygen 
consumption with a Metabolic Rate Meter (MRM, Waters 
Instruments) and obtaining blood samples for arterial-mixed 
venous oxygen content difference. 
The patients were transferred to the clinical cardiavascu- 
Iar physiology laboratory in the cardiovascular intensive 
care unit for the investigative studies. During these studies, 
pulmonary anery diastolic pressure was used as the mea- 
surement of IeR heart filling pressure. as there was excellent 
correlation (r = 0.98. p < 0.001. n = 39 subjects) between 
pulmonary ttrtery diastolic pressure and pulmonary capillary 
wedge presswe. Cardiac output was subsequently measured 
by thermcdilution because of initial excellent correlation 
(r = 0.89. p < O.M)I, n = 29 patients with heart failure) 
between thermodilution and Fick methods of measurement. 
Derived hemodynamic variables were calculated using start- 
dard formulas and included systemic and pulmonary vascu- 
Ix resistance (dynewm~J). cardiac index (literslmin per 
m’l. stroke volume index (ml/beats per m’) and left ventric- 
ular stroke work index @m/m’) (26). 
A direct-writing multichannel physiologic recorder simul- 
taneously recorded phasic arterial. mean (electrical) arterial. 
right atrial and polmonsry artery pre\wrc~ ECti. rc\pir,,- 
tory activity and sympathetic nerve activity to muscle. The 
zero reference pm”, for prewre, wit, defined id the phlc- 
bostatic ilxis in the midaxillory hoe 
Hemodynamic measoremeots in normal subjects. Similar 
invasive hemodynamic mei~roremems wre ohmmed m Ihc 
normal wbjccfs. An nneri;d line wa\ placed m the m:mncr 
described for pdtirnts with heall bilore and a 7.5F tlow- 
directed oximetry thermodilution Sam-Ganz carhercr I\:u\ 
inserted percutaneously at the bedhIde m the left medw 
antecubital vein through an indwelling XF sheath. Complcre 
rest index right heart prssxres and thcrmodilmion cordmc 
output were obtained in all normal \ub~cct\. 
Microneurographic recording US mosctr ynpalhetir nerve 
activity. Multiunit recordings of po\tg;mgliunic \kelct;d 
muscle sympathetic nerve activity were recorded from a 
muscle nerve fascicle in the pcroneal nerve poucnur to ihc 
fibular head in all subiectr. This techmaue ha< been nh- 
dated and extensively described by p&ms mve~t~gator~ 
(27-29) and in studies from our labor&xv (30-33). In brief. 
recordings were obtained hy percutaneous msertion of lung- 
stern microelectrodes into the peroneal ocwe. The clcctrodei 
were connected to a preamplifier. and the nerve signal wu 
fed through a bandpass filter and routed through an ampli- 
tude discriminator to a storage oscillorcape and loud- 
speaker. For recording and analysis. the filtered neurogmm 
was fed through a resistance-capacitance integrating net- 
work to obtain a mean voltage display of the neural actiwty. 
Standard criteria for acceptance of a recording were 
achieved in all subjects (27-33). Nerve activity at rest was 
measured for up to IO min before the study recordings were 
begun to ensure that a stable baseline value of nerve activity 
had been obtained. Sympathetic bursts were identified by 
inspection of the mean voltage nemogram. Individual bunt 
frequency was determined as bursts per minute. Nerve 
activity was also corrected for heart rate and expressed as 
bursts- per 100 heartbeats (331. Previous stud& in our 
laboratorv 1291 determined an intraobserver variabilitv of 5% 
and an interobserver variability of <IO% in this cal&lion 
of sympathetic nerve activity. 
Plasma hormone determinations. Anerial blood simple5 
for plasma norepinephrine were ubtained from the indwcll- 
ing arterial catheter at the completion of the consecutive 5 
min recordings of hemodynamics and sympathetic nerve 
activity. Samples were collected in prechilled heparinized 
tubes god immediately placed on ice. then centhfuged at 
4°C. Norepinephrine levels were assayed by a single isotope 
radioenzymatic method (34.35). with a variability of ~7% for 
this laboratory 
Hemodynamic and sympathetic nerve corretat~on. Sinml- 
toneous nnd conseculive 5 mb! recordings of rat hemady- 
namic variables and efferent muxle Fympathetic nerve ac- 
tivity to muscle were obtained with ail subjects in the supine 
position. Cardiac output WBS determined each minute by 
Ihcrmoddution. and pulmonary artery saturation was moni- 
lored conlinuuusly 10 ensure a \tablc hcmodynamic wtc at 
~c\t. V;duc\ for all hemodynamic and nerve activity wriiv 
hle\ iare the mean wlue~ for the\e 5 min recordings. An 
artcn:d hluod sample fur plav~~a hormone dsterminalionr 
\+a\ ohlamed ut the comple!ion of the ? mm of rccordmg of 
hemody,l;.mu imd \ymparheuc nerve ncrwty. 
Statistical analysis. Values for hemodynamics and sym- 
pothetlc nerve ;actiwty durmg the conwurwe 5 min of 
rccurd~n~\ I” .$I patrent> and are reported as the man 2 
SFkl of md~ridusl minute values. Compariconq of demo- 
graphic. hcmodynamic and sympathetic nerve activity be- 
wcen pouentr uath hean failure and norm~t control whjeac 
wcrc pcrformcd by unpaired I te\t*. Compariwn\ of hemo- 
d,nsmu and demographics among pzatient~ with heart bil- 
urc in functi!mal CIPPS II. III or IV ws performed by 
Malawi\ of variance. Statntical ngniticance was considered 
,I\ p < 0 OF Correlatmn between Fick and thermodilution 
c,urdw outpot delerminatlon\ and hetrvcen pulmonary cap- 
illory wedge and pulmonary artery diastolic pwswrer were 
performed hy linear regression analysis. Multiple linear 
rqrcwon .malyres wew utilized to corre!nte sympathetic 
new activity and hemodynamic variables in all subjcct~ 
grouped together and in the patients with heart feimre alone. 
Patient and normal subject groups. The clinical. echocar- 
diographlc and index hemodynamic chancrerisr~cr of the 
patients with heart failure and normal control wbjects are 
summarized m Table I. The patients with heart failure were 
in New York Heart Asrociation functional class II tn = 71. 
Ill to = I41 or IV (n = 81 at the time of study. The primary 
cholopy for hean failure in these patients included idiopathic 
ddnted cardiomyopathy In = 171. alcoholic cardiomyopathy 
to = 3) and irchemic heart discasc In = 9). The radionuclide 
left vemricular ejection faction in patients with heart failure 
avcragcd 21.3 + 1.4% (range 6% to 40701. The patients with 
heart failure were older than the normal subjects: they 
ranged in age from 24 to 7R years. whereas normal subjects 
ranged from 20 to 31 years. 
Cwuporrd witl~ wraol ,sshjecrs. the patients with heart 
failure had larger cardiac chamber size. reduced left vemric. 
otor ~yslolic function. increased cardiac filling pressure and 
hean rote and reduced mdsc pressure and cardiac index. 
Mean arterial pressure u& sio&r in the two groups. 
Comparison of sympathetic activity at rest in patients with 
heart failure versus normal rubjcts (Fig. 1 and 2). The 
patient, with heart failure had a significantly elevated level 
of wnpalhetic nerve activity compared with the normal 
wb&t;. Efferent muscle sy&pathetic nerve activity aver- 
aged 54.7 r 4.5 burstslmin (range 14.6 to 99.4) in the patients 
with heart failure compared with 16.7 ? 2.2 burstslmin 
(range 8.4 !o 30.6) tp 4 O.WI) in the normal subjects. This 
difTcrcnce could not he accounted for by a difference in the 
heart rilte at rest between the two groups. When sympathetic 
burst freqoency was corrected for simultaveous heart rate. 
the patients with heart failure had significantly greater activ- 
ity (60.8 t 4.2 bursts/It&l heartbeats) than the normal suh- 
jects (24.8 C 2.9 bursts/lOil hearl beats, p < 0.001). Simi- 
larly. the difference between the two groups did not appear 
to be r&ted to age. When the nine patients with heart failure 
Figure 1. Bar graphs comparing muscle sympathetic nerve activity 
(MSNAI at rest in 29 patients with heaR failure and 10 normal 
subjects. Patients with heal failure have significantly higher levek 
of muscle sympathetic nerve activity expressed as bursts per minute 
WI pswll. This increase is not related 10 variation in hear! rate at 
rest because the di6ereace Desists when svmoathe~ic aclivitv is 
corrected for heart rate highihigntt). DataarLm&.n values t SCM. 
hh = heanbeals. 
540 years of age were compared with the IO normal sub- 
jects, the “young” patients with heart failure had signifi- 
cantly greater sympathetic activity (50.5 i: 1.5 burstslmin; 
54.2 + 6.9 burstdltM heartbeats; p < 0.01 versus normal 
subjects) than did the normal subjects. 
Cwreiation between sym@h+tk activity aad htneibnal 
clinkal cllrs (Tsbk 2). The functional cla&ification of the 
patients with heart failure ranged from class II through IV. 
Although the patients in class IV were older and had a lower 
arterial pressure and cardiac output than did the patients in 
classes II and Ill. there was no significant difference among 
the three groups with respect to rest levels of sympathetic 
nerve activity lo muscle. 
Hemodynamk arrelstes of sympathetk aetivlty in normal 
wbj& and palkatr with hart failure (Fig. 2 to 4). When all 
29 patients with heart failure and the IO normal subjects were 
analyzed together, sympathetic nerve activity was found to 
be strongly and inversely correlated with both IeR ventricu- 
lar stroke work index (r = -0.86, p < O.M)oI) and stroke 
volume index (r = -0.85. p < O.ooOl). In this total group of 
39 subjects there were strong positive correlations between 
sympathetic neural activity and pulmonary artery diastolic 
(r = 0.82, P < O.ooOl) and mean (r = 0.81. D < OLQOI) 
pressures (Fig. 2 and 3). 
Moderate inverse correlations were found between mus- 
cle sympathetic nerve activity and arlerial sysrolic lr = 
-0.72. p < 0.0001) and pulse (r = -0.699. p < O.oM)I) 
pressures, thermadilulion cardiac index (I = -U.71. F < 
O.lMlI) and echocardiognphic assessment of left ventricular 
fracdonal shortening (r = -0.72. p < O.MlUI. n = Zhl. 
Moderate positive correlations were established for nympa- 
thetic nerve activity and pulmonary ar.ery systolic pressure 
(r = 0.78. p < O.lWDl). syslemic (r = 0.67. p < O.ooOl) and 
pulmonary (r = 0.74. p < O.ooOl) vascular resistance. heart 
rate (r = 0.71, p < O.ooOl) and echocardiographic measure- 
ments of kfi ventricular end-systolic (r = 0.67. p < 0.001. 
n = 27) and left atrial (r = 0.72. p < O.WlUI. n = 36) 
diometen. 
When rhe 29 parienrs wirh heart /ii/we wcw analym/ 
separately. sympathetic nerve activity to muscle most 
strongly and inversely correlated with left ventricular stroke 
work index (r = -0.81, p < O.WOI) and moderately and 
inversely correlated with stroke volume index (r = -0.75. 
p < O.tXOI). There were moderate positive correlations 
between sympathetic nerve activity and pulmonary artery 
diastolic (I = 0.72. p < 0.00011 and mean (r = 0.70. p 4 
O.fKPIl) pressures. Moderate negative correlalions were ob- 
served among sympathetic nerve activity and arterial sys- 
tolic (I = -0.64, p < 0.001) and pulse (r = -0.66. p i 0 001 I 
pressures and cardiac index (r = -0.B. Q < O.WIL There 
were moderate positive correlations between nerve aclivily 
and pulmonary artery systolic pressure (r = 0.65. p < O.M)I I. 
systemic (I = 0.62. p < 0.001) and pulmonary (r = 0.64. p 4 
2n 100 80 m 
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Figure 3. Correlations between rest muscle sympathetic nerve 
activity (MSNA) and hemodynamic variables in 10 normal subjects 
(triangter) and 29 paderr with heart failure Irid@. There were 
strong inverse correlations between sympathetic nerve acdvity and 
left ventricular stroke work index ILVSWU and stroke volume 
index WI). Strong pxitive forrelalions were determined between 
sympathetic nerve activity and pulmonary artery diastolic (PADP) 
and mean @‘AMP1 pressures. 
O.oOll vascular resistance and artenal and mixed venous 
oxygen content difference (r = 0.68, p < O.OCQI). 
There was no correlation between sympathetic nerve 
activity and left ventricular ejection fraction (by radionuclide 
ventriculography) or cardiac chamber size (by echocardiog- 
raphy) in the patients with heart failure (Fig. 4). 
Neurohumaral and chemical correlrles of sympathetic ac. 
tivity in patients with heart failutx (Fig. 5). Simultaneous 
mea~uremcnts of plasma norepinephrine and sympathetic 
nerve activity were determined in the 29 patients with heart 
failure and revealed a strong positive correlation lr = 0.72, 
p < O.ooOl. n = 26). There was no significant correlation 
between rympathetic nerve activity and serum sodium con- 
centration (r = -0.28. p = 0.13) in the patients with heart 
failure. Similarly, these patients exhibited no significant 
correlation between rest levels of sympathetic nerve activity 
and arterial oxygen tension (r = -0.07. p = 0.72). oxygen 
saturation (r = -0.15, p = 0.45) or oxygen content (r = 
-0.27, p = 0.16). 
Sympathetic nerve activity and cardiac periormance. We 
correlated the degree of sympathetic nerve excitation with 
both rest hemadynamics and noninvasive descriptors of 
*. r ^^ 
Figure 4. Correlations between rest muscle sympathetic nerve 
activity (MSNAI and twninvasive descriptors in 29 patients with 
hean failure. Sympathetic nerve activity did not correlate wilh left 
ventricular ejection fraction &VW, by radionuclidc ventriculogra- 
phy). left ventricular :nddiasmlic diameter (LVED Diam. by eeha 
cardiography). serum sodium (Na) or anedal oxygen tension (p0,l. 
heart failureanda smallergroupof normal subjects. Todate. 
this is the largest detailed study of patients with eart failure 
to simultaneously examine direct recordings of e&rent 
sympathetic nerve activity to muscle and direct hemcdy- 
namic variables of cardiac performance at rest. From these 
studies, we conclude II sympathetic nerve activity pan.lle~ 
the impairment of cardiac performance in patients with eart 
failure: 2) markedly elevated levels of sympathetic activity 
Figure S. Correlation between rest muscle sympathetic nerve activ- 
ity (MSNA) and plasma norepinephrine l vels in 26 padents with 
heart failure. There is a mcderately strong pusidve correlation 
between direct measurements of these two variables. 
carolac penormance I” 1!J patients wtn moaerate to swere Plasma Naednephrlne (p@ml) 
appear to identify patients with heart failure with elevated 
cardiac filling pressures and reduced cardmc performance: 
and 3) muscle sympathetic ncrvc actwy correlate\ wh 
serum determinations of plasma norepinephrme in rhe re\r 
state. 
Comparison with previous human studies. Elevated 
plasma norepinephrine has been described as :i hallmark uf 
heart failure in numerous previous studies in human\ 
(11,14.17,21,23.36-38). The level of norepiwphrine ial re\i 
appears to be related to the prognosis of patienu wh hcarr 
failure (I I .21.23). Although some studies (39.40) uggest that 
the circulating lcvcl of this catccholamine is rewed to the 
hemodynamic status of patients with acute or chronic heart 
failure, others (41) indicate that the level of plasma norepi- 
nephrine is pot related to rest cardiac index. left heart filiing 
pressure or mean arterial pressure in patienis wth chrome 
heart failure. 
Plasma norepinephrine is derived prtmardy by neuronal 
release and subsequent spi!lover into the circulation. with 
only a small amount being derived from the adrenal medulla. 
Plasma levels of this catecholamine have been implicated BC 
markers of sympathetic nerve activity in both normal hu- 
mans and patients with heart disease 142-47). However. 
several potential variables in studies of patients with heart 
failure could alter the relation between plasma norepmeph- 
rine and efferent sympathetic nerve activity. These variables 
include the potential for I) facilitated release of the catechol- 
amine from adrenergic nerve terminals. 21 variability of 
regional norepinephtine inactivation by means of neuronal 
reuptake before spillover into the circulating plasma. 3) 
variability of sampling sites for determinations of plasma 
norepinephrine. 4) alterations in rate of norepinephrine 
removal from the circulation in disease states. and 5) intlu- 
ewe of concomitant pharmacologic agents on norepineph- 
rine kinetics or autonomic mechanisms. For example. angi- 
otensin (known to be elevated in many patients with heart 
failure [I 1.14-231) facilitates release of norepinephrine from 
sympathetic nerve terminals (48.49). In addition. regional 
rates of norepinephrine spillover and raptake vary widely 
among various organ beds in humans. with norepineptrine 
r&ax being greatest in the lungs (50). Certain disease states 
such as hypertension and heart failure are associated with a 
decrease in removal of norepinephrine from the circulation 
(51-53). Finally, certain pharmacologic agents such as anti- 
depressants and beta-adrenergic blocking agents have been 
shown to reduce norepinephrine clearance (X54-56). 
Plasma norepinephrine and sympatkelic nerve activity. 
The observations reported in the present study avoid many 
of the potential pitfalls in previous studies that used plasma 
norepinephrine levels to assess sympathetic activity in pa- 
tients with heart failure. In the present study. we measured 
&rent sympathetic nerve activity directly and obtained 
simultaneous determinations of circulating norepinephrine 
levels. Thus, we were able to simulteneously assess sympa- 
therx dcrivity by both direct tmicroneuropraphicl and indi- 
rect Iplasma norepmephnne) methods and correlate theye 
nxawrcment~ with Ihe hemodynamic swus both m normal 
subject\ and m patients with hean failure. Care was taken fo 
cnwc that p~uenls and normal wbjcctq were no! receiving 
medxalion known to alter autonomic mechanisms or penph- 
cral mctabohim ci norcpinephrine at the time of thc.study 
In partsular. no patient war receiving digitalis glycosides. 
uhxh have recently been shown to have autonomic effects 
in paGent\ rrnh heart failure (33.57). In addition, patient5 
v&c excluded if they had significant disorders other than 
heart falure ihat are known to be wsociated wh abnormal- 
atie\ of \)mpitthetic neural control mechanisms. 
The first direct measurements of symvathetic nerve ac- 
twty m pahents with hean failure were previously reported 
from our laboratory by Leimbach et al. (241. These prelim- 
inary observations in a separate and smaller group of&xmal 
subJects and patients with heart failure clear!9 demonstrated 
that patxntr with heart failure have markedly elevated levels 
of rympethetic nerve activity compared with normal sub- 
jects. This heightened sympathetic activity at rest was not 
relaxd 10 the age of the patient NT to the heart rate at rest. 
These initxd observations are confirmed by the separate and 
larger ~1:~s reported in the present study. In addition. the 
obscrvatwns by Leimbach et ill. (24) revealed a correlation 
beween plasma norepinephrine levels and muscle sympa- 
thetic nerve activity tr = 0.80. 0 < 0.001. n = IS) very 
similar to that obgehed in the pr&ent study. 
Luin,hach PI RI. (241 observed n srm,!~ cnrrela~ion he- 
twctw rpmpnthrtic mvw nrfhify nnd curdiuc pfiiw prer- 
sms. bu: found no correlation between sympathetic nerve 
activity and cardiac index. systemic vascula.r resistance or 
left ventricular ejeclion fraction. The present study confirms 
the lack of correlation between sympatheti; nerve activity 
and left ventricular ejection fraction, but does demonstrate 
rignificant correlations between sympathetic nerve activity 
and cardiac index. stroke volume index. left ventrict!!m 
stroke work index and systemic and pulmonic vascttlar 
resistance. These differences may relate to the larger sample 
size iat the present study. These new findings support the 
concept that sympathoexcitation in heart failure reflects the 
degree of impairment of cardiac performance at rest in 
patients with moderate to severe heart failure. 
Potential mechanisms of sympatbaexcitalion in heart bil- 
we. Although the present studies were not designed to 
specifically address the potential mechanisms responsible 
for the observed increase in sympathetic outflow from the 
central nervous system in patients with heart failure. they do 
provide wme insight. Muscle sympathetic nerve activity is 
regulated primarily by baroretlex. chcmoreflea and somatic 
reflex mechanisms (27-32.58-64). Cenlral sympathoexcita- 
don may result from either an increase in excitatory influ- 
ences or a decrease in inhibitory influences on brainstem 
canliovascularcenters. Excitatory influences that are known 
to increase efferent sympathetic outflow include activalion 
of metaboreceptors in exercising muscle (the somatic pres- 
sor reflex) and activation of arterial chemoreceptors during 
hypoxia. We observed marked sympathoexcitation in pa- 
tients with heart failure who were at rest and did not have 
arierial hypoxemia. This suggests that activation of excita- 
tory &rent influences does twt account for the marked 
increases in efferent muscle sympathetic nerve activity in 
these patients with heart failure. 
The mmr likely explanarion for the increase in central 
symparhrric orrtJkw observedin ourparienls is a decrease in 
the tonic inhibitory restrain( that baroreflex mechanisms 
exert on the medullary cardiovascular centers (65). Impair- 
ment of “low pressure” cardiopulmonary baroreflexes has 
been documented in experimental models of heart failure 
(66-68) and has been suggested in clinical studies of hem 
failure (57,69-74). The degree of impairment of these auto- 
nomic control mechanisms appears to rellect the severily of 
the underlying cardiac condition (72.73). Arterial baroreflex 
control of the circulation is also impaired in animals with 
heart failure (75.76). Impairment of sinoaonic baroreflex 
control of heart rate has been demonstrated in patients with 
a variety of cardiac disorders (77-79). Although the mecha- 
nism of such baroreflex impairment remains to be clarified, 
recent studies (80) suggest that immediate reversal of the 
severe heart failure state after cardiac transplantation is 
accompanied by early nornmlization of arterial barnreflex 
mechanisms in patients. 
Pn~ential limiiations ofpresont studii. We recognize sev- 
eral potential limitations in the interpretation of these stud 
ies. All measurements were performed in supine human 
subjects nt rest in a temperature-controlled environment. 
The relations between hemodynamic variables and sympa- 
thetic nerve activity in this condition may not reflect the 
correlation between these physiologic variables during states 
of circulatory stress such as exercise or upright posture. 2) 
Measurements of muscle sympathetic nerve activity were 
derived from only one Site, the pemneal nerve. Differences 
exist in the control of sympathetic nerve activity to various 
tissues and vascular beds (28.29); however, at least in 
normal subjects al rat, spontaneously occurring fluctuations 
in muscle sympathetic nerve activity are remarkably similar 
in different limb sites (81). This suggesfs that a recording of 
activity at rest from one nerve is representative of aclivily 
from other nerves and that the preganglionic influence on 
this postganglionic sympathetic activity is relarively tmi- 
form. 
3) The patients with heart failure as a group were older 
than the normal control subjects and we eannot completely 
exclude the pntential for this age difference lo have affected 
the comparisons between sympathetic activity in the two 
groups. However, as noted under Results, when “young” 
patients with heart failure were compared with nnrmal 
subjects of similar age, there was still a significant difference 
in sympathetic nerve activity at rest. Indeed. some of these 
younger patients exhibited marked impairment in cardiac 
function and markedly increased levels of sympalhetic ae- 
tivity. 4) Finally, norepinephrine samples in the present 
study were obtained from an arterial access she in the 
patients with heart failure. Because there is marked regional 
variability in plasma norepinephrine levels, the samples 
obtained probably do not reflect this variability. However, 
the reasonably close correlation between individual patient 
values for sympathetic nerve activity and plasma norepi- 
nephrine pmvides complementary data regarding the degree 
of sympathoexcitation in these patients. 
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